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Task sharing is a strategy with potential to increase access to effective modern
contraceptive methods. This study examines whether community health ex-
tension workers (CHEWs) can insert contraceptive implants to the same safety
and quality standards as nurse/midwives.We analyze data from , clients of
CHEWs and nurse/midwives who participated in a noninferiority study con-
ducted in Kaduna and Ondo States, Nigeria. Adverse events (AEs) following
implant insertions were compared. On the day of insertion AEs were simi-
lar among CHEW and nurse/midwife clients—. percent and . percent,
adjusted odds ratio (aOR) . ( percent CI .–.)—but noninferior-
ity could not be established. At follow-up . percent of CHEW clients and
. percent of nurse/midwife clients experienced AEs. There was strong evi-
dence of effect modification by State. In the final adjusted model, odds of AEs
for CHEW clients in Kaduna was . ( percent CI .–.) compared to
nurse/midwife clients, and . ( percent CI .–.]) in Ondo. Noninfe-
riority could not be established in either State. Implant expulsions were higher
among CHEW clients (/) compared to nurse/midwives (/). Re-
sults show the feasibility of training CHEWs to deliver implants in remote rural
settings but attentionmust be given to provider selection, training, supervision,
and follow-up to ensure safety and quality of provision.
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INTRODUCTION
Like many countries, Nigeria has a severe shortage of health workers (WHO 2012; Federal
Ministry of Health 2014; Akeju et al. 2016) along with inequitable geographic distribution
and an imbalance in the range of health worker skills. Physicians and nurses tend to be
concentrated in tertiary care facilities, and shortages are most acute in rural and northern
parts of the country (Federal Ministry of Health 2014; Awofeso 2010). Task sharing is a
potentially cost-effective means to increase access to health services for people living in areas
with a shortage of health workers. Essentially it allows a wider range of cadres, including less
qualified health workers to offer certain services, when deemed safe and effective (WHO
2017). WHO has endorsed the strategy as a means to increase access to reproductive health
services, including access to long acting reversible contraceptives (LARCs) (WHO 2017),
defined here as implants and intrauterine contraceptive devices (IUCD). In 2014, lower
cadre Community Health Extension Workers (CHEWs) were approved by the Government
of Nigeria to insert and remove contraceptive implants and IUCDs after appropriate train-
ing (Federal Ministry of Health 2014). Prior to this, provision of LARCs was restricted to
midwives, nurses, and physicians.
Senior CHEWs—the focus of this study—make up 27 percent of the workforce in
Nigeria’s primary health care units (vs. 8 percent nurses and midwives) (Federal Ministry
of Health 2014). They are classified as “upper-lower” health staff and undergo three years
of training (Evidence to Action Project 2017). They are often located in more remote areas
compared to more highly qualified cadres (Federal Ministry of Health 2014). In larger urban
centers CHEWs assist nurses and physicians; in rural health centers they work alone or
with another CHEW or nurse. Although CHEWs are expected to spend half their time
on community-based functions, in reality they spend most of their time in clinics due to
shortages of higher cadre staff in many rural areas (Abdul-hadi et al. 2013; Kress, Su, and
Wang 2016; Uzondo et al. 2015).
In Nigeria, one in four married women has an unmet need for family planning (Per-
formance Monitoring and Accountability (PMA2020) 2018). Modern contraceptive use,
estimated at 12 percent among married women (National Population Commission (NPC)
[Nigeria] and ICF 2019), varies significantly by geographic zone (7.8 percent in the North
East vs. 24.3 percent in the South West), state (1.7 percent in Yobe State vs. 29.0 percent
in Lagos State), residence (18.2 percent in urban areas vs. 7.8 percent in rural areas),
socioeconomic status (3.7 percent among the poorest vs. 22.2 percent among the rich-
est), education and religion (National Population Commission (NPC) [Nigeria] and ICF
2019). Short-acting methods predominate (Performance Monitoring and Accountability
(PMA2020) 2018), and LARCs are used by 35 percent of modern method users (implants
28.3 percent and IUCDs 6.7 percent) (National Population Commission (NPC) [Nigeria] and
ICF 2019).
The Government of Nigeria committed to increasing the prevalence of modern contra-
ceptive use among all women from 15 percent in 2016 to 27 percent by 2020 and to scale up
access to modernmethods (FP2020 2019; Guttmacher Institute 2019). LARCs offer particular
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benefits to women over short-term methods, including higher effectiveness, longer contin-
uation, fewer contraindications, and in some settings, higher cost-effectiveness (Mazza et al.
2016; Mavranezouli 2008; Shoupe 2016; Trussell et al. 2015). Despite several initiatives in
Nigeria to increase access to modern methods, including task-sharing provision of LARCs
with CHEWs (Charyeva et al. 2015; Blumenthal et al. 2013; Shelton and Finkle 2016), a
recent study found method choice and access to LARCs remains limited, slowing increase
in modern contraceptive use (Thanel et al. 2018).
WHO recommends that auxiliary nurses (WHO 2014) provide contraceptive implants
under close monitoring and evaluation before they fully endorse this cadre for implant
provision globally (WHO 2017). CHEWs are the closest equivalent to this cadre, but they
have three years of medical training. Studies from several sub-Saharan Africa countries
show that provision of contraceptive implants by lower cadre health workers can increase
access to and use of LARCs (Thanel et al. 2018; Asnake et al. 2013). Two studies have assessed
the acceptability and feasibility of implant provision by CHEWs in Nigeria. The first, a
pilot study in rural Sokoto and Bauchi States, tested the feasibility of training CHEWs
to provide implants, documenting CHEW knowledge and skills, client acceptability, and
effectiveness of supportive supervision mechanisms (Charyeva et al. 2015). The study found
CHEWs consistently followed clinical protocols and delivered high-quality services, but
observed challenges with low client flow. The second feasibility study, in Kaduna and
Cross-River States, observed high-quality implant insertions. The study also investigated
effects on contraceptive method mix and found an increase in implant provision over-
all (Morgan et al. 2017). Neither study evaluated insertion-related clinical outcomes nor
compared CHEW provision with higher cadre health workers. In their guidance on task
sharing, WHO highlights the lack of studies on the safety and effectiveness of contra-
ceptive implant insertion and removal with lower cadre health staff (Polus et al. 2015;
WHO 2012).
The proper insertion and removal of implants are essential for clinical efficacy and for the
prevention of complications, such as infection, neurovascular injury (Lefebvre et al. 2018), im-
plant migration, or expulsion (Rowlands and Searle 2014). Complications related to insertion
and removal procedures, although rare, may include pain, paresthesia, bleeding, hematoma,
scarring, or infection. Implant removalmay be difficult if the implant is not inserted correctly,
inserted too deeply, not palpable, encased in fibrous tissue, or has migrated. Deep insertions
maymake the implant difficult to locate andmay require a surgical procedure in an operating
room to remove the implant (Implanon USA 2019). Research is urgently needed to establish
whether task-sharing implant insertions with lower level health staff is clinically safe and of
acceptable quality.
This study compares insertion-related adverse events (AEs) due to implant insertions by
newly trainedCHEWsor nurses/midwives.We also compare the quality of implant insertions
and client satisfaction. The overall goal is to provide scientific evidence on the safety of this
form of task sharing for national and state health authorities. In addition, the study aimed to
provide robust data on insertion-related clinical side effects and moderate and severe AEs in
a low-income setting.
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METHODS
Study Setting
The study was conducted in public health facilities in two Nigerian states, Kaduna in cen-
tral northwest Nigeria, and Ondo in the southwest. The north and the south differ culturally,
socially, and economically, with the south tending to be richer, and with better health and
socioeconomic indicators compared to the north, including maternal, infant and child mor-
tality, education, contraceptive prevalence, distribution ofmedical schools, and availability of
health care providers (Makinde et al. 2018; International Organization for Migration (IOM)
2014). Kaduna State is the third most populous state in Nigeria, with an estimated population
of 8.25 million, compared to 4.18 million in Ondo State in 2016. Sixty-six percent of the pop-
ulation in Kaduna State is under the age of 25, compared to 59 percent in Ondo State (Nigeria
Bureau of Statistics 2019). Forty seven percent of women aged 15–49 years in Kaduna State
have no education, compared to 7.9 percent in Ondo State. The total fertility rate (TFR) in
Kaduna was 5.9 with a mean ideal number of children of 7.2 children, compared to a TFR of
4.1, and a mean ideal number of children of 4.5 in Ondo. In Kaduna 36.5 percent of house-
holds live in the poorest two wealth quintiles compared to 21.2 percent in Ondo (National
Population Commission (NPC) [Nigeria] and ICF 2019).
Study Design and Intervention
This was a quasi-experimental noninferiority study that aimed to compare insertion-related
moderate and severe AEs resulting from insertion of contraceptive implants by CHEWs with
nurses and midwives. Random allocation of clients to intervention groups was not possible
in this study because clients access their local area clinics. Also, providers could not be ran-
domized because they work at either CHEW-led or at nurse- or midwife-led public clinics.
The methodology and detailed description of the intervention is provided in the published
protocol https://doi.org/10.2196/resprot.8721 (Reiss et al. 2018). Briefly, 12 out of 23 local gov-
ernment areas (LGAs) were purposively selected from Kaduna State, and seven of 23 LGAs
from Ondo State. LGAs that shared reproductive health interventions funded by the same
donor and implemented across several LGAs, as well as those that were geographically hard-
to-reach were excluded from the sampling frame.
Facilities in remaining LGAs were eligible for inclusion if they were CHEW or
nurse/midwife led; had not previously provided implants; had provided family planning ser-
vices for at least three years; had a provider interested in participating in the study who ex-
pected to remain at the facility for the 12-month client recruitment period; and, finally could
offer onsite referral, or were within 20 km of a referral facility in case of implant insertion
or removal complications. From 657 facilities operating in these LGAs, 93 were eligible for
inclusion in the study. Seventy-seven were primary basic health units (BHUs) or small rural
hospitals and 16 were secondary or tertiary centers or hospitals.
We aimed to select 60 providers (30 CHEWs and 30 nurse/midwives) from each state.
Providers from the 93 facilities were invited to participate in the study if they met the fol-
lowing criteria: they had no prior implant training or provision experience; were resident
in the LGA; expected to remain at the health facility for the 12-month client recruitment
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period; and lastly, that they had good verbal and written communication skills. In total 119
providers were included in the study. A single provider was recruited from 67 facilities; and
two providers from the remaining 26 facilities. This comprised two CHEWs from 15 facilities
and two nurse/midwives from 11 facilities.
Providers comprised 30 nurses/midwives from each state; and 30 CHEWs from Ondo
and 29 from Kaduna State. Providers were trained by 13 supervisors, themselves trained by
Marie Stopes Nigeria (MSION) in family planning counselling, insertion and removal of im-
plants, management of AEs, and study procedures. For a full description of training and su-
pervision procedures see Reiss et al. (2018).
Two implant brands were initially included in the study: Implanon Classic® (one rod
preloaded in trocar) offering three year protection from pregnancy; and Jadelle® (two rods,
with separate disposable trocar) offering five year protection. ImplanonNXT® was introduced
into Nigeria partway through the study and accounted for 2.6 percent of insertions during
the study period. Posttraining, providers went through a facility-based accreditation process,
providing implant insertions and removals under supervision. After five successful super-
vised insertions and two successful supervised removals of both Jadelle® and either Implanon
Classic® or ImplanonNXT®, providers were qualified to insert and remove implants with-
out clinical supervision. Postaccreditation, each provider received visits every two to three
weeks from their study supervisor, supported by aMSIONclinical supervisor, a quarterly visit
from the State Ministry of Health, and a bi-annual visit from the Federal Ministry of Health
(FMoH) and a study principal investigator. During these visits providers received study up-
dates and, if required, additional training. MSION also implemented demand generation ac-
tivities around each facility, including advocacy with local stakeholders and engagement of
mobilizers (health promoters) to help promote and publicize service availability.
Client Enrolment and Data Collection
Between November 30, 2015 and November 30, 2016, all clients attending the selected facili-
ties, aged 18–49 years, and who voluntarily chose an implant following comprehensive con-
traceptive counselling were invited to participate in the study. Written informed consent was
obtained from all study participants by the provider. This included consent for follow-up at
the clinic or by telephone. Immediately following implant insertion, the provider completed
a structured questionnaire to record participants’ demographic and background characteris-
tics, and experience of any insertion-related clinical AE during and immediately postinser-
tion (Table 1). All AEs, including those classified as more minor events or side effects were
recorded. AEs were categorized into one of three levels: (1)Minor (side effect): The client ex-
periences some level of discomfort that only requires resting or minimum level of medical
intervention such as taking pain medication; (2)Moderate (complication): The client experi-
ences frequent or more severe level of discomfort that requires a medical intervention and/or
expulsion of implant resulting in risk of unintended pregnancy; (3) Major/critical (compli-
cation): Major injury leading to long-term incapacity/disability and requires hospitalization
and/or results in fatality, or expulsion of implant resulting in pregnancy.
Women were invited to return for follow-up two weeks postinsertion. At follow-up, they
were reconsented to ensure they remained willing to participate, and providers completed a
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TABLE  Implant insertion-related AEs recorded on day of insertion and at follow-up
Description of adverse event
Recorded on day of implant insertion
Anaphylactic reaction to the implant
Implant insertion unsuccessful on first or second attempt
Implant breaks
Palpitations resulting from the local anesthetic
Recorded at follow-up
Expulsion of implant
Paresthesia due to neural damage (numbness, tingling, tickling, pricking, or burning sensation at implant site)
Pain post procedure for >1 week and requires further outpatient observation and medical intervention.




Recorded on day of implant insertion and at follow-up
Hematoma / bruising requiring medical intervention
Bleeding around the insertion site
Other adverse reaction requiring medical treatment or resulting in long-term incapacity or fatality
structured questionnaire to record all AEs experienced since insertion. Women who did not
return to the clinic were followed-up by phone by the provider, with up to three attempts
made.
Clinical supervisors visited every provider within the first month following training (ac-
creditation), then again one, two, three, and six months post-accreditation to assess the qual-
ity of implant insertions. Visits lasted one to two days, during which all implant insertions
were observed and data on quality recorded (Reiss et al. 2018). They used a 28-item checklist
(Online Appendix T1) to record competence in preinsertion counselling, preinsertion prepa-
ration, insertion technique, postinsertion procedures, and counselling. An overall score of
28/28 was defined as high quality. Supervisors also conducted client satisfaction exit inter-
views among a subsample of participants. Women were considered highly satisfied if they
rated seven aspects of care as “good” or “very good” (Online Appendix T2).
Outcome Measurement
We had two primary outcomes for this study: (1) insertion-related moderate or severe AEs
at the time of insertion, and (2) insertion-related moderate or severe AEs overall, measured
at the time of insertion and at follow-up. Secondary outcomes were (1) quality of implant
insertions observed by clinic supervisors, and (2) client satisfaction with implant insertion
measured through client exit interviews.
Sample Size and Noninferiority
Thiswas a noninferiority study designed to assesswhether the proportion of insertion-related
moderate/severe AEs among CHEW clients was not higher than a specified amount than the
proportion of moderate/sever AEs among nurse/midwife clients. Insertion-related AEs are
rare and based on outcome data from clinical trials (Reiss et al. 2018; Meirik et al. 2013), and
agreement of the research team, we assumed a base rate of 0.5 percent for moderate/severe
AEs among clients of nurse/midwives on the day of insertion. The noninferiority margin,
or predetermined benchmark of acceptable difference between the two groups for the day
of implant insertion was set at 0.5 percent. In other words, we consider that CHEWs are
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noninferior to nurses/midwives if the upper confidence bound of the difference in AE rates
(CHEWS – nurse/midwives) is not higher than 0.5 percent.
In the absence of any data on moderate/severe insertion related AEs at follow-up, we
assumed a base rate of 1 percent at follow-up, with a noninferiority margin of 1 percent. We
combined data from the day of insertion and follow-up to give a total complications score.
The target sample size required to measure moderate/severe AEs on the day of insertion
assuming a noninferiority margin of 0.5 percent, 80 percent power, 95 percent confidence, a
design effect of 1.5 (for clustering by provider), and 10 percent incomplete records was 8,125.
The target sample size for the same outcome at follow-up, assuming a noninferiority margin
of 1 percent and a loss to follow-up of 20 percent, was 4,410.
To assess the quality of insertions, we assumed 80 percent would be rated good based on
Marie Stopes International’s (MSI’s) previous quality audits with nurses inmultiple countries,
with a noninferiority margin of 10 percent. We assumed that the noninferiority margin re-
ferred to a difference in proportions, meaning that if the lower 95 percent confidence limit
for the difference in proportions is −0.10 or greater, then we can conclude that CHEWs are
noninferior to nurse/midwives in terms of quality.
Data Analysis
We used Stata software version 15 (StataCorp 2017) for the statistical analyses. All analyses
were adjusted for clustering by provider. Outcomes were analyzed using Generalized Esti-
mating Equations (GEE) models where nested models were compared using Wald tests. Co-
variates were excluded from the models where they were not statistically significant at the
5 percent level and when data were too sparse to support more complicated models. Effect
modification was examined for several key covariates (state, facility type, implant type, in-
study insertion experience). Due to a large variation in the timing of follow-up visits (which
were beyond the study team’s direct control), we extended the follow-up interval from two
weeks to include data up to 75 days postinsertion.
For the primary outcomes, noninferiority was assessed by modeling odds ratios (OR)
rather than risk differences. Since the AEs rates were so low the odds is a very close ap-
proximation to the risk difference. Assuming a prevalence of moderate/severe AEs among
nurses/midwives of 0.5 percent on the day of insertion, and a risk difference of no more than
0.5 percent, the corresponding noninferiority margin expressed as an odds ratio is 2.01. As-
suming prevalence ofmoderate/severeAEs of 1 percent by day 14 (follow-up), the correspond-
ing odds ratiomargin is 2.02. For the secondary outcome—quality of insertions—proportions
were within the range where it is reasonable to assume linearity and so difference in propor-
tions was modeled directly using GEE rather than converting to odds ratios.
We examined background characteristics and differences between CHEW clients and
nurse/midwife clients among all those with complete primary outcome data for the day
of insertion. Simple proportions and frequencies for categorical variables and means for
continuous variables are shown. We then compared insertion-related AEs among clients of
each provider at the time of insertion, and overall. We present proportions reporting spe-
cific AEs as well as an overall AE prevalence for each provider, with unadjusted odds ratios
and 95 percent confidence intervals (CIs) for comparison. For the multivariate analysis, we
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investigated several potential confounders. Contributions to themodel fit were assessed using
Wald tests. Variables were included in the model if the p-value was <0.05, or if there was ev-
idence of confounding whereby the estimated effect (nurses/midwives vs. CHEWs) changed
by 10 percent or more. Provider level co-variates were state, rural location of facility, facil-
ity type (BHU/small hospital vs. tertiary hospital), number of in-study insertions conducted
by provider, and other provider present at facility. Individual client characteristics were age,
number of living children, education, marital status, previous family planning use, brand of
implant, distance travelled, residential location, household drinking water source (proxy for
household poverty), and employment status. We conducted stratified analyses to assess po-
tential effect modification by selected individual and contextual characteristics listed above.
Effect modification was considered statistically significant if the interaction term p-value was
<0.05.We found some effect modification by state and adjusted the final model. Models were
sensitive to choice of variables, likely due to the small number of AEs.
Missing Data
Themultivariate analyses to assess insertion-related AEs occurring on (1) the day of insertion
and (2) overall, (on the day of insertion and at follow-up), were conducted on all observations
with complete data for covariates. On the day of insertion, 98 observations or 1.3 percent of
observations from each cadre (53 nurse/midwife clients; 45 CHEW clients) had missing data
for at least one of the variables included in the finalmodel (implant brand, number of previous
in-study insertions, and employment status) and were excluded from the analysis. Excluded
observations did not include any AEs. For the combined outcome, there were no missing
observations.
Sensitivity Analyses
We conducted four sensitivity analyses (Online Appendix T4 and T5) by repeating the pri-
mary analyses while excluding or including selected subgroups to determine if they had an
inordinate effect on the estimatedmeasure of effect, and noninferioritymargin. Three of these
sensitivity analyses were predetermined, and one was data driven. The latter excluded outlier
providers, or those with relatively high rates of AEs; defined as a provider with more than
10 AEs, or above the 25 percentile for AEs, with more than five expulsions, or above the 25
percentile for expulsions. We conducted three sensitivity analyses to investigate how best to
address issues with missing or incomplete data, and these included (1) exclusion of obser-
vations with low-quality insertions; (2) exclusion of observations with low-quality follow-up
dates; (3) inclusion of observations with less than half missing outcome components, and
inclusion of observations with any missing outcome components.
Supervision and Safety Monitoring
During study implementation supervisors visited all providers every two to three weeks to
provide study and clinical support. Study participants were encouraged to return to the facil-
ity if they had concerns or experienced any AEs. The study followed standard FMoH/MSION
management and reporting protocols requiring immediate reporting to the clinical services
manager of severe and moderate AEs, and within 24 hours for minor events. The clinical
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services manager was responsible for ensuring effective management of AEs, and that all AEs
were reported to the studymanager. Severe AEswere reported toMSI’sMedical Development
Team in London within 24 hours.
Ethics
Ethical approval was obtained fromMSI’s Ethics Committee,NationalHealth Research Ethics
Committee of Nigeria and the Population Council Institutional Review Board. This study is
registered with ClinicalTrials.gov, number NCT03088722.
RESULTS
One hundred and nineteen providers (60 nurse/midwives; and 59 CHEWs) across 93 health
facilities took part in the study between November 30, 2015 and November 30, 2016. In total,
they inserted 7,883 implants (4,195 nurse/midwife clients; and 3,688 CHEW clients). Figure 1
shows the flow of insertion clients by provider included in this analysis. Of the total number
of clients, 2.1 percent nurse/midwife clients and 2.8 percent CHEW clients were excluded
from analysis of AEs occurring on the day of insertion, mostly due to missing information
on the primary outcome. Complete data on AEs occurring on the day of procedure were
available for 4,107 nurse/midwife clients and 3,584 CHEW clients (N= 7,691). Of these 3,517,
or 85.6 percent of nurse/midwife clients and 2,987, or 83.3 percent of CHEW clients were
successfully followed up within 75 days (N = 6,504). In total 15.5 percent of respondents
included in analysis of AEs at the time of insertion were lost to follow-up due to problematic
follow-up dates or missing AE outcome at follow-up (see Figure 1). This included a total
of 590 (14.4 percent) of nurse/midwife clients and 597 (16.7 percent) of CHEW clients. Of
those lost to follow-up due to problematic follow-up dates (N = 746), there were 11 AEs: two
among nurse/midwife clients and nine among CHEW clients. Those lost to follow-up were
significantly more likely to be CHEW clients compared to nurse/midwife (p = 0.001); urban
compared to rural (19.3 percent vs. 11.9 percent; p ≤ 0.001); from Ondo compared to Kaduna
State (20.0 percent vs. 10.8 percent; p≤ 0.001); primary educated compared to secondary (17.1
percent vs. 13.8 percent; p≤ 0.001); employed compared to unemployed (16.4 percent vs. 13.3
percent; p ≤ 0.001); and had chosen to use Implanon® compared to Jadelle® (16.4 percent vs.
14.3 percent; p ≤ 0.05). Loss to follow-up did not vary significantly by distance to facility, age
of respondent, or type of facility.
For the secondary outcome (quality of implant insertion), all providers were observed
at least once. This comprised observations of 1,064 nurse/midwife clients and 781 CHEW
clients. The analysis sample comprised 883 (83 percent) observations from54nurse/midwives
and 537 (69 percent) observations from 50 CHEWs across 86 facilities (see Figure 2). Incor-
rect date of implant observations was the main reason for exclusion of observations from the
analysis (164 nurse/midwife clients and 210 CHEW clients).
Background Characteristics
Table 2 presents data at the provider level. Providers were equally distributed by state and
urban/rural location, but CHEWs were significantly more likely to be based at a BHU than
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FIGURE  Study flow chart for AEs (primary outcome)
nurse/midwives (93.3 percent vs. 64.4 percent; p ≤ 0.001) and less likely to work alone (53.3
percent vs. 61.0 percent; p ≤0.001). The mean number of insertions conducted during the
study was significantly lower among CHEWs compared to nurse/midwives (54.3 vs. 62.5; p
= 0.040). Table 3 presents data on client’s background, by provider. The mean age of clients
was 30 years with little difference between CHEW and nurse/midwife clients; they had four
children on average (4.1 for CHEW vs. 3.7 for nurse/midwife clients; p ≤ 0.001); and almost
all weremarried. Compared to nurse/midwife clients, CHEW clients were less educated (57.6
percent had primary or less vs. 47.6 percent; p ≤ 0.001), more likely to be unemployed (38.6
percent vs. 29.8 percent; p≤ 0.001) and to live in a household without access to treated water
(31.9 percent vs. 17.3 percent; p ≤ 0.001). CHEW clients were also less likely to want to limit
their number of children (26.4 percent vs 34.8 percent; p ≤ 0.001), and significantly more
likely to be nonusers of modern contraceptive methods in the previous three months (70.8
Studies in Family Planning () September 
Douthwaite et al. 
FIGURE  Study flow chart for insertion quality
TABLE  Characteristics of newly trained providers and facilities included in the study in
Kaduna and Ondo States, Nigeria
Total (%) Nurse/midwife clients (%) CHEW clients (%) p-valueCharacteristic of
facility and provider (N = ) (N = ) (N = )
State (% in Kaduna) 49.6 49.2 50.0 0.926
Facility location (%
rural)
51.3 50.9 51.7 0.929
Facility type (% basic
health unit)
79.0 64.4 93.3 ≤0.001
Other providers on site
(% working alone)




58.4 62.5 (6-189) 54.3(3-107) 0.040
percent vs. 62.9 percent; p ≤ 0.001). They were also less likely to receive the longer-acting
Jadelle® implant (43.0 percent vs. 50.8 percent; p≤ 0.001) compared to nurse/midwife clients.
Primary Outcome: Insertion-Related AEs
Nomajor/critical complications were recorded during the study. Table 4 showsmoderate and
severe AEs on the day of insertion were rare. Overall 40 clients reported 48 specific AEs oc-
curring on the day of insertion. All results are adjusted for clustering by provider, showing
an overall percentage of 0.46, and 0.51 percent among CHEW clients’ vs. 0.41 percent among
nurse/midwife clients. In the crude analysis, the odds ratio is 1.27 (95 percent CI 0.31-5.14).
After adjustment for provider’s previous in-study insertion experience, implant brand, and
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TABLE  Client background characteristics by cadre (nurse/midwife or CHEW) among those
with complete primary outcome data for insertion-related AEs occurring on day of insertion in
Kaduna and Ondo States, Nigeria
Total (%) Nurse/midwife clients (%) CHEW clients (%) p-value
Client characteristics (N = ,) (N = ,) (N = ,)
Age (mean years) 30.1 30.4 29.8 0.008
Missing (n) () () ()
Marital status (% married) 97.6 97.3 98.0 0.040
Missing (n) () () ()
Number of children (mean) 3.9 3.7 4.1 ≤0.001
Missing (n) () () ()
Fertility intentions (%
limiting)
31.1 34.9 26.8 ≤0.001
Missing (n) () () ()
Education (% primary or less) 51.2 46.3 56.8 ≤0.001
Missing (n) () () ()
Occupation (% unemployed) 33.0 28.5 38.2 ≤0.001
Occupation (%
manual/agricultural)
30.8 33.5 27.8 ≤0.001
Occupation (%
sales/services/clerical)
25.6 26.7 24.4 0.024
Occupation (%
professional/student)
10.5 11.3 9.5 0.012
Missing (n) () () ()
Wealth (% without treated
water source)
24.1 17.3 31.9 ≤0.001
Missing (n) () () ()
Modern FP use (% not using
in last 3 months)
66.5 62.9 70.8 ≤0.001
Missing (n) () () ()
Implant brand inserted (%
Jadelle®)
47.2 50.8 43.0 ≤0.001
Missing (n) () () ()
client’s employment status (unemployed vs. employed) the odds ratio falls to 0.92 (95 percent
CI 0.38-2.23). (Table 5). Other potential confounders mentioned in the methods were ex-
plored during the analysis and were found to have no or negligible effect on estimates. These
included rural location of facility, facility type (BHU/small hospital vs. tertiary hospital), and
individual client characteristics such as age, number of living children, education,marital sta-
tus, previous family planning use, brand of implant, distance travelled, household drinking
water source (proxy for household poverty), and employment status.
Of those followed up (N = 6,504), 255 clients experienced at least one AE at insertion
and/or follow-up (overall prevalence of 4.27 percent) (Table 4). These 255 reported 317 AEs
in total occurring between insertion and follow-up. The most common was implant ex-
pulsion (overall prevalence of 3.15 percent; 5.24 percent among CHEW clients; 1.15 percent
among nurse/midwife clients). CHEW clients were more likely to report all types of AEs, ex-
cept scarring, and reported an overall higher prevalence of AEs than nurse/midwife clients
(6.6 percent vs 2.1 percent; crude odds ratio [cOR] 3.17, 95 percent CI 1.32-7.57, p = 0.010)
(Table 4).
Further analysis of the combined AEs outcome showed some evidence of effect modi-
fication by state. Results in Table 5 show the striking difference in AEs by provider in each
state. Of the total 255 AEs reported, 203 occurred in Kaduna State, of which 160 occurred
among CHEW clients. In the final adjusted model stratified by state, CHEW clients in
Kaduna experienced an elevated odds of AEs compared to nurse/midwife clients (adjusted
Studies in Family Planning () September 
Douthwaite et al. 
TABLE  Comparison of implant insertion-related AEs by cadre among clients with complete
primary outcome data for day of insertion, and insertion-related AEs occurring on day of
insertion and up to  days later, Kaduna and Ondo States, Nigeria
a





Moderate or Severe AEb AEs % AEs % AEs % cOR % CI
At least one AE occurring
on day of insertion
 .  .  . . .–.
Specific AEs occurring at insertion
Bruising or hematoma 27 0.30 15 0.30 12 0.30 0.97 0.15–6.40
Bleeding around insertion
area
19 0.24 8 0.18 11 0.31 1.69 0.45–6.40
Implant breaks 1 0.01 0 0.0 1 0.03 – –









At least one AE occurring
on day of insertion
 .  .  . . .–.
Specific AEs occurring at insertion
Bruising or hematoma 22 0.27 14 0.32 8 0.22 0.69 0.08–5.69
Bleeding around insertion
area
14 0.21 7 0.19 7 0.23 1.23 0.33-4.58
Implant breaks 1 0.02 0 0.0 1 0.03 – –
(Other) Oedema 1 0.02 0 0.0 1 0.03 – –
At least one AE
occurring up to 
days after insertion
 .  .  . . .–.
Specific AE occurring up to 75 days after insertion
Pain around insertion site 31 0.46 14 0.34 17 0.59 1.74 0.38–8.03
Bruising or hematoma 6 0.10 4 0.05 2 0.16 3.42 0.27–42.93
Post insertion bleeding 4 0.07 1 0.03 3 0.11 3.95 0.30–52.27
Infection 13 0.22 3 0.09 10 0.36 3.85 0.79–18.55
Paraesthesia 9 0.15 3 0.09 6 0.21 2.24 0.43–11.88
Scarring 23 0.35 16 0.45 7 0.25 0.56 0.19-1.70
Expulsion 182 3.15 40 1.15 142 5.24 4.54 1.41–14.58
Occurring on day of
insertion or follow-up
 .  .  . . .–.
Bruising or hematoma 24 0.31 10 0.32 14 0.30 0.95 0.14–6.56
aAll results are adjusted for clustering by provider
bNone of the following AEs were reported, anaphylactic reaction, palpitations.
odds ratio [aOR] 3.34, 95 percent CI 1.53-7.33). In Ondo State, CHEWs compare favorably
with nurse/midwives (cOR 0.79, 95 percent CI 0.37–1.68), but after adjustment for previous
in-study insertion experience, and other providers at the facility, there was no evidence that
CHEWs were noninferior to nurse/midwives (aOR = 0.72, 95 percent CI 0.19–2.72) as the
upper bounds of the 95 percent confidence limit exceeded the noninferiority margin of aOR
2.02 (Table 5). Further analysis showed AEs fell with increased in-study insertion experience
for both providers in both states (Figure 3).
Sensitivity Analyses
Several individual CHEWs in Kaduna were associated with relatively high rates of moder-
ate or severe AEs (see Online Appendix T3). Elevated levels of AEs are defined earlier in the
methods section. To determine whether providers with elevated levels of AEs had an inor-
dinate effect on the estimated measure of effect, we repeated the primary analyses for both
outcomes, excluding providers with elevated levels of AEs, and stratifying by state for both
primary outcomes (see Online Appendix T4 and T5) In most scenarios when providers with
elevated AEs were excluded from the analysis, there remained no evidence that CHEWswere
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TABLE  Comparison of implant insertion-related AEs by cadre among clients with complete
primary outcome data for day of insertion, and overall (day of insertion and at follow-up), in
Kaduna and Ondo States, Nigeria
Unadjusteda Adjusted
N AEs % OR % CI N OR % CI
Day of insertion
Nurse/midwives 4,107 19 0.41 1.00 4,054 1.00b –
CHEWs 3,584 21 0.51 1.27 0.31-5.14 3,539 0.92 0.38–2.23
Day of insertion and at follow-up combined
Ondo state Nurse/midwives 1,786 33 1.85 1.00 – – 1.00c –
CHEWs 1,314 19 1.46 0.79 0.37–1.68 – 0.72 0.19–2.72
Kaduna state Nurse/midwives 1,731 43 2.39 1.00 – – 1.00c –
CHEWs 1673 160 12.01 5.03 1.53–16.54 – 3.34 1.53–7.33
aAdjusted for clustering by provider.
bMultivariate model adjusts for clustering by provide, implant brand, previous in-study insertion experience, employed status
cMultivariate model adjusts for clustering by provider, previous in-study insertion experience, other provider at facility and CHEW##state
interaction
FIGURE  Comparison of implant insertion-related AEs by in-study implant insertion
experience, by provider among clients with complete primary outcome data for day of insertion
& follow-up
noninferior to nurse/midwives—in other words, the upper bounds of the 95 percent confi-
dence limit remained greater than the noninferiority margin of 2.01 or 2.02. The exception to
this was for the combined outcome in Ondo State where the upper bound of the 95 percent
confidence limit decreased to 1.95 for CHEWs versus nurses/midwives, when provider 2109
was excluded (see Online Appendix T5 Primary outcome 2, Sensitivity Analysis 1). This is
accompanied by a reduction in aOR in Kaduna State, fromOR= 3.34 to OR= 2.70, which is
expected because the excluded provider was a CHEW from Kaduna. This analysis provides
some (weak) evidence that CHEWs could be considered noninferior to nurses/midwives
in Ondo State. Several additional sensitivity analyses were conducted for both primary
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outcomes. In every scenario, the upper confidence limits remained greater than the noninfe-
riority margin of 2.01 or 2.02 (see Online Appendix T4 and T5) implying that the results are
robust to themethods for dealing withmissing/incomplete data because the upper 95 percent
CI remains above the threshold.
Secondary Outcomes
Quality of Implant Insertion and Client Satisfaction
Table 6 shows the results for the secondary outcomes—quality of insertions observed by the
clinic supervisors (see Online Appendix T1 for quality checklist), and client satisfaction,mea-
sured through client exit interviews (see Online Appendix T2). Unadjusted results are ad-
justed for clustering on provider. Overall 70 percent of insertions scored 28 out of 28 in quality
assessments defined here as good quality (67 percent among CHEWs and 73 percent among
nurse/midwives). Providers in Ondo—both CHEWs and nurse/midwives—were more likely
to score 28 out of 28 in quality assessments compared to providers in Kaduna. In the crude
analysis, the proportion of CHEWs rated good was 6.2 percent lower than nurse/midwives,
with a 95 percent confidence interval of −21.6 percent to 9.3 percent. In the adjusted anal-
ysis the difference in proportion of good quality CHEWs compared to nurses/midwives fell
to 4.8 percent with a 95 percent confidence interval of −15.2 percent to 5.5 percent, but the
lower bounds of the 95 percent confidence interval was below the noninferiority margin of
−10 percent, so we cannot conclude that insertion quality for CHEWs was noninferior to
nurses/midwives.
Sixty-three percent of nurse/midwife clients were highly satisfied with the experience of
implant insertion compared to 56.2 percent of CHEW clients (Table 6), meaning that they
rated all seven satisfaction components as “good” or “very good” (see Online Appendix T2).
After adjusting for state, other provider at facility, urban/rural location, and type of facility,
there was insufficient evidence of a difference in the proportion of highly satisfied CHEW
clients vs. nurse/midwife clients (0.15 percent, 95 percent CI −0.160 to 0.163; p = 0.985) (Ta-
ble 6). We did not assess noninferiority for satisfaction. Almost all clients (99.3 percent) said
they would recommend the service to a friend.
DISCUSSION
This analysis, using data from 7,691 women, assessed whether CHEWs can insert implants to
the same safety and quality standards as nurses and midwives in Kaduna and Ondo States in
Nigeria. The primary outcome focused on insertion-related moderate and severe AEs during
or shortly after implant insertion. Although moderate and severe AEs were rare, we were un-
able to conclude that CHEWs were noninferior to nurse/midwives because the upper limit of
the adjusted 95 percent confidence interval exceeded the noninferiority margin of 2.01 (aOR
0.92; 95 percent CI 0.38–2.23), although the difference between the two groups overall was
not statistically significant. While AEs were rare, CHEW clients experienced an increased
odds ratio of AEs by the time of their follow-up visit, the main driver of which was high ex-
pulsion rates. The observed expulsion rate of 3.15 percent overall and 5.24 percent among
CHEW clients is far higher than rates reported elsewhere: a rate of 0.0 percent–0.6 percent
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of spontaneous expulsion without infection (Brache et al. 2002; Ramdhan et al. 2018). While
infection can lead to implant expulsion (Ramdhan et al. 2018), we found little evidence of
this in our study, with infection rates of 0.36 percent among CHEW clients and 0.09 per-
cent among nurse/midwife clients, in line with rates of 0.2–1.4 percent reported elsewhere
for Jadelle® (Brache et al. 2002).
The causes of the high expulsion rates are not fully understood. Poor surgical tech-
nique, superficial implant insertion, and/or poor counselling may have played a role. Anec-
dotal evidence from early on in the study linked implant expulsion to heavy lifting, and
increased attention was given to counselling women to avoid heavy lifting in the first 48
hours after insertion. We could not conclude that the quality of CHEW care was noninferior
to nurses/midwives, although the difference in quality between the two groups overall was
not statistically significant. With fewer years of training, and less overall clinical experience,
CHEWs may well be less skilled compared to nurse/midwives. The expulsion problem was
concentrated in seven poor performing CHEWs (see Online Appendix T3). The AE mod-
els were sensitive to the inclusion or exclusion of CHEWs with elevated rates of AEs, but
exclusion of providers with elevated AEs did not change our overall conclusions. While all
providers completed an accreditation process prior to initiating study enrolment, our data
show that in-study insertion experience played a critical role, since the expulsion rate fell
with increased insertion experience through the study (Figure 3). While implant expulsion
does not constitute a serious clinical complication, it is potentially unpleasant or painful, puts
the client at renewed risk for pregnancy and is likely to require additional visits with a health
provider. This result indicates that greater attention to provider accreditation and supervi-
sion is essential to ensure the safety of this service delivery mechanism. Screening may also
be needed to ensure only those with sufficient clinical competency are selected to undergo
training on this method.
The poorer quality of care observed in Kaduna versus Ondo State is also of concern.
Kaduna is more rural and economically poorer than Ondo, and like many of Nigeria’s more
northern states may benefit from the new LARC task-sharing policy. It is therefore impera-
tive that future expansion of implant provision by CHEWs in these states is adequately super-
vised and quality assured. Failure to adequately assure quality in such services may also have
longer-termdetrimental effects on efforts to promote and sustain family planning in these set-
tings: fears about the health impacts of contraception are a well-evidenced barrier to uptake
(Ajayi, Adeniyi, and Akpan 2018), and studies indicate that certain elements of quality can
influence contraceptive behavior (Jain et al. 2014; Fruhauf et al. 2018; RamaRao et al. 2003).
This is, to our knowledge, the largest clinical study to-date of implant provision con-
ducted in a real-life service provision context in a low-income setting, albeit with additional
supervision and monitoring activities in place. Study findings shed light on the challenges
of both training through a cascade approach, and in assuring quality, particularly in remote
regions. Findings have important implications for wider quality improvement processes
throughout public and private service delivery networks and demonstrate the need to
regularly follow-up women postservice delivery to monitor clinical outcomes, including
implant or IUCD expulsions. Observing our outcomes in remote locations, however, meant
restrictions on study design and consequent limitations which must be considered. First,
the observational design implies potential selection bias; while we attempted to control for
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confounding between groups, there is likely still unmeasured confounding in the sample,
particularly because the CHEW and nurse/midwife cadres are designed to reach different
areas and client types. For example, we lacked poverty probability index data and relied on a
proxy measure of wealth—source of household drinking water—when assessing the effects
of wealth in our models. Second, the CHEWs included in our study were not representative
of all CHEWs in these states. They were required to have three years training, were a senior
CHEW cadre, and were selected based on communication competency. Third, reporting bias
is likely since AE data were collected by providers themselves. It is likely that CHEWs could
have reported events differentially to nurses/midwives—overestimating events if less skilled
or experienced to deal with AEs, or underestimating due to fear of negative consequences.
Fourth, the attrition of providers through the research process may have led to underreport-
ing of AEs because those with the poor data quality may have also experienced elevated AEs.
Fifth, quality data collected by supervisorsmay have been biased by the fact that the groups of
supervisor observers differed by state; since the indicators included were partially subjective,
this may also help to explain why scores were so different in the two states. Finally, the calcu-
lation of noninferiority margins assumed a “true” prevalence of AEs among nurse/midwives
of 0.5 percent at insertion. In our sample, the prevalence was closer to 0.4 percent. This
prevalence would imply in turn a noninferiority margin of OR = 2.26 (vs. the 2.01 assessed).
While this would not affect conclusions from the primary analysis for all AEs, this revised
upper margin would lead to a different conclusion, that is, that there is evidence that CHEWs
are noninferior to nurse/midwives on the day of insertion (aOR: 0.92; 95 percent CI 0.37–
2.23; p = 0.848). Since the “true” prevalence among nurses/midwives remains unknown, we
could not justify basing our conclusions on the highermargin of OR 2.26 rather thanOR 2.01.
In conclusion, our study shows the feasibility of training CHEWs to deliver LARCs in re-
mote, rural regions in low-income countries, but family planning programs must pay greater
attention to provider selection, accreditation, training, and supervision procedures to ensure
quality and safety of provision. The challenges identified in this study may also be exacer-
bated in situations where other health programs are also using task sharing as a scale-up
mechanism, and there remains an important risk that CHEWs (or equivalent) become over-
burdened with increasing complexity of work at the primary care level (Schaefer 2015). Also,
successful task sharing of implants requires enough client demand for providers to maintain
competency and confidence (Schaefer 2015) —a possible challenge in remote, rural settings,
such as northern Nigeria. Our intervention involved substantive demand generation activi-
ties that provided sufficient client flow for the study, and the fact that quality improved with
insertion experience demonstrates that task sharing and demand generation must go hand
in hand. The study also importantly demonstrates the need for programs to conduct regular
postservice follow-up of implant provision to assess postservice outcomes such as expulsion,
in particular in rural regions with known quality concerns. This is also likely to be recom-
mended for IUCDprovision too, where expulsion is known to be a common clinical outcome
(Jatlaoui, Riley, andCurtis 2017;Madden et al. 2014), yet understudied in low-income settings.
If these types of quality assurance are followed, task sharing of implant provision to clinically
trained community health workers can still be a powerful intervention to support national
governments achieve scale in delivery of LARCs in settings with high unmet need for family
planning.
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